Companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering. Includes companies specializing in protein-based therapeutics to treat human diseases. Excludes companies manufacturing products using biotechnology but without a health care application.
The Biotechnology industry has on average risen 119.1% over the last 3 months. The average price/earnings ratio is 53.1 and the average return on equity is 108.8%. These averages are based on an equal weighting of the 413 most liquid stocks in this industry.
Symbol | Company Name | Setup | TA | FA | CRS | % Chg | 1 Month | 3 Month | 6 Month | PE | Market Cap | Vol(50) | Action |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 81.44 | -0.11% | 3.35% | 19.82% | 22.54% | 21.53 | 402.76B | 5.50M | ||||
| AMGN | AMGEN INC | 22.56 | -0.39% | 6.88% | -4.83% | 3.89% | 13.38 | 157.07B | 2.26M | ||||
| GILD | GILEAD SCIENCES INC | 81 | 0.17% | 7.89% | 4.08% | 17.22% | 15.63 | 150.06B | 6.97M | ||||
| VRTX | VERTEX PHARMACEUTICALS INC | 17.97 | -0.29% | 9.24% | -10.28% | -14.67% | 24.88 | 108.04B | 1.53M | ||||
| REGN | REGENERON PHARMACEUTICALS | 13.53 | 0.39% | 2.49% | 2.64% | -4.1% | 12.66 | 61.26B | 1.04M | ||||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 92.11 | -0.12% | 3.81% | 40.94% | 84.22% | N/A | 60.75B | 1.09M | ||||
| ARGX | ARGENX SE - ADR | 90.28 | 0.63% | 14.85% | 38.06% | 32.95% | 88.74 | 50.32B | 356.26K | ||||
| ONC | BEONE MEDICINES LTD-ADR | 0 | 0.25% | -4.68% | 6.64% | 26.91% | 5.02 | 34.14B | 275.32K | ||||
| INSM | INSMED INC | 95.64 | -0.29% | 16.51% | 53.59% | 129.1% | N/A | 33.75B | 2.14M | ||||
| NTRA | NATERA INC | 91.97 | -1.28% | 18.13% | 38.6% | 25.18% | N/A | 26.42B | 1.09M | ||||
| BNTX | BIONTECH SE-ADR | 22.62 | 0.87% | 7.73% | -8.37% | 3.57% | N/A | 25.40B | 912.30K | ||||
| BIIB | BIOGEN INC | 29.91 | -0.13% | 9.11% | 13.97% | 26.13% | 9.36 | 21.98B | 1.61M | ||||
| UTHR | UNITED THERAPEUTICS CORP | 85.62 | -1.79% | -3.25% | 37.46% | 43.65% | 16.34 | 18.93B | 808.53K | ||||
| GMAB | GENMAB A/S -SP ADR | 85.5 | 0.07% | 2.82% | 27.74% | 45.17% | 14.87 | 18.40B | 2.06M | ||||
| INCY | INCYTE CORP | 88.25 | 2.21% | 10.37% | 30.03% | 54.29% | 17.45 | 17.83B | 1.75M | ||||
| SMMT | SUMMIT THERAPEUTICS INC | 11.51 | 2.83% | -7.97% | -32.75% | -17.84% | N/A | 14.32B | 4.39M | ||||
| NBIX | NEUROCRINE BIOSCIENCES INC | 77.61 | 0.23% | 1.41% | 8.98% | 34.92% | 42.6 | 14.28B | 781.53K | ||||
| ROIV | ROIVANT SCIENCES LTD | 92.55 | 0.55% | 20.11% | 57.75% | 65.49% | N/A | 12.44B | 7.69M | ||||
| EXAS | EXACT SCIENCES CORP | 73.25 | -0.32% | 20.66% | 33.31% | 42.19% | N/A | 12.24B | 2.46M | ||||
| ASND | ASCENDIS PHARMA A/S - ADR | 89.16 | 0.49% | 5.21% | 20.62% | 23.06% | N/A | 12.22B | 431.71K |